Explainer: Bayer's Supreme Court Case Impact on Roundup Lawsuits

• Bayer argues EPA's finding of no cancer risk preempts state law claims for failure to warn; a ruling in its favor would eliminate failure-to-warn claims but not negligence or misrepresentation claims in existing lawsuits
• The company reached a $7.25 billion settlement in February to resolve most current and potential future lawsuits, with final approval hearing scheduled for July
• Plaintiffs must decide by June 4 whether to opt out of the settlement and continue litigation, potentially before the Supreme Court issues its ruling

Bayer Faces Supreme Court Hearing on Roundup Lawsuits

The U.S. Supreme Court will hear arguments Monday in a pivotal case that could significantly impact Bayer's liability in approximately 65,000 pending Roundup lawsuits. The case centers on whether federal pesticide labeling laws preempt state-level warning requirements.

Key Case Details:

The dispute involves plaintiff John Durnell, who was awarded $1.25 million by a Missouri jury after allegedly developing non-Hodgkin lymphoma from Roundup exposure. Bayer argues that since the EPA found no cancer risk and requires no warning label, plaintiffs cannot claim the company violated state laws by omitting cancer warnings. The Trump administration supports Bayer's position.

Financial Impact:

Bayer reached a $7.25 billion settlement in February with attorneys representing a nationwide class of plaintiffs who claim Roundup caused their cancer. The settlement received preliminary approval in March, with final approval pending at a July hearing. The deal covers most existing and potential future claims from individuals already exposed to Roundup.

Market Implications:

A Supreme Court ruling favoring Bayer, expected by end of June, would significantly weaken remaining lawsuits by eliminating failure-to-warn claims. However, it wouldn't automatically dismiss all cases, as plaintiffs have also alleged negligence, misrepresentation, and product defects. The settlement terms remain unchanged regardless of the court's decision.

Critical Timeline:

Plaintiffs must decide by June 4 whether to accept the settlement or opt out and continue litigation—potentially before the Supreme Court issues its ruling. Those opting out face stronger headwinds if Bayer prevails, while settlement participants are unaffected by the court's decision.

The case represents a crucial juncture in decade-long litigation over one of America's most widely used weedkillers.